x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

MedTech Global Insights

What"s next in the future of health? Welcome to MedTech Global Insights, the podcast dedicated to uncovering the most disruptive technologies and brilliant minds in the medical field. Whether you"re an industry professional, investor, or simply curious, subscribe for your dose of cutting-edge information and expert commentary.

science life sciences

All Episodes

02:09

Pure Global: Brussels' MedTech Crisis - Surviving a...

MedTech Global Insights ·

2026/04/24

Last week, the European MedTech landscape was thrown into chaos. A major Notified Body was suddenly delisted, leaving hundreds of device manufacturers with invalid CE marks and effectively halting their market access overnight. This episode of MedTech Global Insights dissects the fallout from this regulatory earthquake.We explore the immediate operational and financial panic this creates for companies of all sizes. We also discuss the strategic missteps that left many vulnerable and, more

en

01:38

Pure Global: USA's New IVD Regulatory Maze After LDT...

MedTech Global Insights ·

2026/04/23

In this episode, we dissect the FDA's monumental decision to regulate Laboratory Developed Tests (LDTs) as medical devices, ending a long-standing policy of enforcement discretion. We explore what this regulatory shift means for the diagnostics industry, from small hospital labs to large commercial players. This change introduces significant new hurdles for labs that have historically developed and used their own tests without direct FDA oversight. We break down the multi-year transition plan and

en

01:47

Pure Global: Silicon Valley's Cardio Tech Endgame

MedTech Global Insights ·

2026/04/22

This episode of MedTech Global Insights unpacks the massive $13.1 billion acquisition of Shockwave Medical by Johnson & Johnson. We explore the groundbreaking sound-wave technology that made Shockwave a prime target and analyze what this deal reveals about the "buy vs. build" strategy dominating the cardiovascular device market.Imagine your innovative medical device is finally gaining traction. Suddenly, a market giant acquires your main competitor, reshaping the entire competitive landscape

en

01:57

UK AI MedTech Chaos: Pure Global's Guide to the New...

MedTech Global Insights ·

2026/04/21

This week, MedTech Global Insights dives into the sudden regulatory shift from the UK's MHRA, which has enforced a new, stricter framework for AI medical devices. This unexpected announcement creates significant hurdles for global manufacturers, particularly those relying on EU or US data for their product validation. We explore how this divergence from EU regulations impacts market access and what it means for the future of MedTech in the UK. We feature a case study of "CardioAnalytics," a

en

02:09

Pure Global: UK/US Fast-Track, The MedTech Alliance's...

MedTech Global Insights ·

2026/04/20

This week on MedTech Global Insights, we dissect the major announcement of a new regulatory alignment between the UK's MHRA and the US FDA. This move could potentially reshape market access strategies for medical device manufacturers, offering a streamlined path to two of the world's largest markets. We go beyond the headlines to explore the practical implications, hidden challenges, and strategic decisions that companies must now confront. We look at what this alignment truly means for your

en

02:09

Pure Global: US QMSR Gaps Beyond ISO 13485 Compliance

MedTech Global Insights ·

2026/04/19

This week, we dive into the most significant shift in U.S. MedTech regulations in years: the FDA's new Quality Management System Regulation (QMSR). While it harmonizes with the global ISO 13485 standard, manufacturers who assume their existing certification is a free pass for U.S. market compliance are in for a rude awakening. This episode exposes the critical gaps between ISO 13485 and the final QMSR rule. We move beyond the headlines to reveal the specific U.S. requirements in areas like

en

01:35

Pure Global: US FDA's Cancer Device Win & The Hurdle...

MedTech Global Insights ·

2026/04/18

This week, we dissect the groundbreaking FDA approval of a first-of-its-kind device for pancreatic cancer. This new technology, which combines focused ultrasound with AI targeting, offers new hope for patients but also shines a light on the critical challenges that follow a regulatory victory.We explore the often-underestimated 'valley of death' that occurs after a device is approved. For the company behind this innovation, the celebration is short-lived as they now face the immense pressure of

en

02:01

US AI MedTech's Boardroom Blunder: A Pure Global...

MedTech Global Insights ·

2026/04/17

The wall between MedTech innovation and regulatory compliance is crumbling. A recent surge in regulatory expectations for digital health and AI-powered devices is forcing a radical shift in corporate strategy. What was once a final hurdle before launch is now a critical, C-suite-level decision that must be integrated from the earliest stages of product design.This episode of MedTech Global Insights explores why your company's technology architecture is now inseparable from its regulatory fate. We

en

02:07

Pure Global: Brazil & Korea's MDSAP Domino Effect on...

MedTech Global Insights ·

2026/04/16

This week, we dive into a major strategic shift in the MedTech landscape. In early April, regulatory bodies in both Brazil and South Korea made pivotal announcements strengthening their integration of the Medical Device Single Audit Program (MDSAP). This signals a powerful move towards global harmonization, creating unprecedented opportunities for efficient market access.In this episode of MedTech Global Insights by Pure Global, we break down what these changes truly mean. We explore how a single

en

02:00

EU MedTech Cyber Crisis: Pure Global on Post-Attack...

MedTech Global Insights ·

2026/04/15

A targeted ransomware attack on a German hospital network has exposed critical vulnerabilities in thousands of connected medical devices, triggering an emergency regulatory response from the European Union. This episode of MedTech Global Insights unpacks the incident and the urgent new cybersecurity mandates facing manufacturers.We explore the far-reaching implications of the new 72-hour security patch requirement. This isn't just a technical problem; it's a fundamental business model challenge

en

01:56

Pure Global: Europe's Widening AI MedTech Approval Maze

MedTech Global Insights ·

2026/04/14

The regulatory gap for AI-powered medical devices between the United States and Europe is widening into a major challenge for MedTech innovators. What was once a straightforward path—FDA approval followed by a European CE Mark—is now a complex maze of diverging requirements, forcing companies to rethink their entire global strategy from day one. This episode delves into the critical differences between the FDA’s iterative, post-market focused approach and the EU’s stringent, pre-market scrutiny

en

01:51

Pure Global: Brussels' AI MedTech Compliance Traps

MedTech Global Insights ·

2026/04/13

This week, we dissect the EU's surprising new cybersecurity guidance for AI medical devices. Released just last week, this new framework moves beyond traditional compliance, demanding that MedTech innovators build dynamic, continuous defenses against sophisticated AI-specific threats like adversarial attacks and model drift. This shift creates immediate, complex challenges for companies that previously achieved CE marking. We explore how this new regulatory layer requires a complete rethinking of

en

01:44

Pure Global: EU IVD Chaos - Navigating the...

MedTech Global Insights ·

2026/04/12

In this episode of MedTech Global Insights, we dissect the immense challenges and strategic implications of the European Union's In Vitro Diagnostic Regulation (IVDR). With transition deadlines looming, a critical bottleneck in Notified Body capacity is putting thousands of products at risk of being forced off the market. We explore what this regulatory shift really means for manufacturers worldwide.We go beyond the regulations to discuss the real-world business impact. This episode covers the

en

02:12

Washington's AI MedTech Rules: Pure Global on Hidden...

MedTech Global Insights ·

2026/04/11

The U.S. FDA just released pivotal new draft guidance for AI and Machine Learning-enabled medical devices, creating new challenges and opportunities for manufacturers. This episode of MedTech Global Insights provides a concise breakdown of what this policy means for the industry and your product strategy. We explore the specific requirements of the new predetermined change control plans and what they demand from developers before their products ever see the market.We go beyond the regulatory text

en

01:40

Pure Global: USA IVD's Seismic Shift on Lab-Developed...

MedTech Global Insights ·

2026/04/10

The U.S. FDA has finalized its rule to regulate laboratory-developed tests (LDTs) as medical devices, ending decades of enforcement discretion. This landmark decision imposes significant new requirements on clinical laboratories, aligning them with traditional IVD manufacturers and creating a new set of complex challenges for market access and compliance.This shift will require labs to navigate a multi-year transition into full FDA compliance, including premarket reviews, quality system

en

01:56

Pure Global: ASEAN's New MedTech Gateway in Malaysia...

MedTech Global Insights ·

2026/04/09

This week, we dive into the new medical device regulatory reliance pilot program launched between Malaysia and Thailand. This collaboration creates a powerful fast-track for market access in the ASEAN region, allowing companies to leverage an approval in one country to accelerate registration in the other, but the pathway is filled with critical nuances.We explore how this program fundamentally changes the strategic map for Southeast Asia. It's a game-changer for companies that previously faced

en

02:03

Pure Global: USA's 510(k) Cybersecurity Ambush for...

MedTech Global Insights ·

2026/04/08

Last week, the U.S. FDA began strict enforcement of new cybersecurity rules for medical devices, catching many global manufacturers by surprise. This sudden shift requires a complete software bill of materials (SBOM) and a proactive security plan, leading to submission rejections and significant market delays for unprepared companies.This episode of MedTech Global Insights dives into the immediate impact of the FDA's new stance. We break down what this means for device makers, from startups to

en

02:02

Pure Global: US FDA's 510(k) Code Red on Cybersecurity

MedTech Global Insights ·

2026/04/07

The U.S. FDA has drawn a new line in the sand for MedTech innovators. With its "refuse to accept" policy now in effect for 510(k) submissions lacking robust cybersecurity measures, the rules for market entry have fundamentally changed. This episode breaks down the new mandatory requirements, including the crucial Software Bill of Materials (SBOM) and post-market surveillance plans that are now non-negotiable. We explore the immediate and long-term strategic impacts on MedTech companies. This isn't

en

01:52

Europe's IVDR Deadline Chaos: A Pure Global Survival...

MedTech Global Insights ·

2026/04/06

The European Union has once again extended the transition deadlines for the In Vitro Diagnostic Regulation (IVDR), creating both relief and confusion for diagnostic manufacturers. This episode of MedTech Global Insights breaks down what this latest delay really means for the industry and your business strategy. We go beyond the headlines to explore the strategic dilemmas facing companies. Is this extension a lifeline or a trap that penalizes proactive companies that invested millions to be ready on

en

01:55

USA's MedTech Cyber Walls: Pure Global on FDA's...

MedTech Global Insights ·

2026/04/05

In the last week of March, the US FDA dramatically escalated its cybersecurity requirements for wirelessly connected medical devices, creating new, complex hurdles for manufacturers. This move signals a major shift from passive checklists to demands for proactive threat management, catching many international companies unprepared and threatening their access to the world's largest MedTech market.This change is not just about documentation; it's about a fundamental re-engineering of a product's

en

239 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter